Tracon Pharmaceuticals Company Profile (NASDAQ:TCON)

About Tracon Pharmaceuticals

Tracon Pharmaceuticals logoTRACON Pharmaceuticals, Inc. (TRACON) is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics for cancer, age-related macular degeneration (AMD) and fibrotic diseases. The Company's research focuses on antibodies that bind to the endoglin receptor, which is essential to angiogenesis (the process of new blood vessel formation) and a contributor to fibrosis (tissue scarring). The Company's lead product candidate, TRC105, is an anti-endoglin antibody that is being developed for the treatment of multiple solid tumor types in combination with inhibitors of the vascular endothelial growth factor (VEGF) pathway. Its other anti-endoglin antibody is TRC205, which is in preclinical development for the treatment of fibrotic diseases. The Company is also developing TRC102, a small molecule that is in clinical development for the treatment of lung cancer and glioblastoma.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: TCON
  • CUSIP:
Key Metrics:
  • Previous Close: $6.30
  • 50 Day Moving Average: $5.45
  • 200 Day Moving Average: $6.25
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.94
  • P/E Growth: 0.00
  • Market Cap: $76.88M
  • Outstanding Shares: 12,203,000
  • Beta: 2.94
Additional Links:
Companies Related to Tracon Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Tracon Pharmaceuticals (NASDAQ:TCON) (?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $20.50 (225.40% upside)

Analysts' Ratings History for Tracon Pharmaceuticals (NASDAQ:TCON)
Show:
DateFirmActionRatingPrice TargetDetails
8/19/2016BTIG ResearchInitiated CoverageBuy$15.00View Rating Details
2/1/2016Oppenheimer Holdings Inc.Reiterated RatingOutperformView Rating Details
10/8/2015Roth CapitalReiterated RatingBuyView Rating Details
3/2/2015Stifel NicolausBoost Price TargetBuy$16.00 -> $20.00View Rating Details
2/24/2015Wells Fargo & Co.Initiated CoverageOutperformView Rating Details
2/24/2015Needham & Company LLCInitiated CoverageBuy$19.00View Rating Details
(Data available from 8/29/2014 forward)

Earnings

Earnings History for Tracon Pharmaceuticals (NASDAQ:TCON)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/1/2016        
8/10/2016Q2($0.62)($0.68)ViewListenView Earnings Details
5/11/2016Q1($0.70)($0.54)ViewListenView Earnings Details
2/18/2016Q4($0.62)($0.91)ViewListenView Earnings Details
11/3/2015Q3($0.51)($0.53)ViewListenView Earnings Details
8/5/2015Q215($0.42)($0.24)$4.20 millionViewListenView Earnings Details
5/13/2015Q1($0.37)($0.50)ViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Tracon Pharmaceuticals (NASDAQ:TCON)
Current Year EPS Consensus Estimate: $-2.38 EPS
Next Year EPS Consensus Estimate: $-2.14 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.56)($0.56)($0.56)
Q2 20162($0.70)($0.46)($0.58)
Q3 20162($0.75)($0.48)($0.62)
Q4 20162($0.85)($0.50)($0.68)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Tracon Pharmaceuticals (NASDAQ:TCON)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Tracon Pharmaceuticals (NASDAQ:TCON)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/3/2016Ronald L ShazerInsiderSell1,003$7.48$7,502.44View SEC Filing  
10/16/2015Jafco Super V3 Investment LimiMajor ShareholderSell1,500$9.90$14,850.00View SEC Filing  
10/15/2015Jafco Super V3 Investment LimiMajor ShareholderSell5,300$10.16$53,848.00View SEC Filing  
10/13/2015Jafco Super V3 Investment Limimajor shareholderSell3,168$10.01$31,711.68View SEC Filing  
10/9/2015Jafco Super V3 Investment Limimajor shareholderSell1,448$10.01$14,494.48View SEC Filing  
10/8/2015Jafco Super V3 Investment Limimajor shareholderSell21,920$10.10$221,392.00View SEC Filing  
10/5/2015Jafco Super V3 Investment Limimajor shareholderSell15,100$10.08$152,208.00View SEC Filing  
9/25/2015Jafco Super V3 Investment LimiMajor ShareholderSell7,600$12.13$92,188.00View SEC Filing  
9/24/2015Jafco Super V3 Investment Limimajor shareholderSell22,303$12.99$289,715.97View SEC Filing  
9/22/2015Jafco Super V3 Investment Limimajor shareholderSell39,426$14.02$552,752.52View SEC Filing  
9/21/2015Jafco Super V3 Investment Limimajor shareholderSell18,200$14.48$263,536.00View SEC Filing  
9/18/2015Charles TheuerCEOSell10,000$17.34$173,400.00View SEC Filing  
9/18/2015H Casey LoganinsiderSell5,000$17.34$86,700.00View SEC Filing  
9/17/2015Jafco Super V3 Investment Limimajor shareholderSell42,344$11.78$498,812.32View SEC Filing  
9/14/2015Jafco Super V3 Investment Limimajor shareholderSell60,038$11.78$707,247.64View SEC Filing  
9/10/2015Charles TheuerCEOSell3,516$12.00$42,192.00View SEC Filing  
9/9/2015Jafco Super V3 Investment Limimajor shareholderSell12,000$10.71$128,520.00View SEC Filing  
9/8/2015Jafco Super V3 Investment Limimajor shareholderSell5,700$10.47$59,679.00View SEC Filing  
9/4/2015Jafco Super V3 Investment Limimajor shareholderSell6,600$10.48$69,168.00View SEC Filing  
9/3/2015Jafco Super V3 Investment Limimajor shareholderSell15,300$10.51$160,803.00View SEC Filing  
9/1/2015Jafco Super V3 Investment Limimajor shareholderSell14,000$10.42$145,880.00View SEC Filing  
8/24/2015Jafco Super V3 Investment LimiMajor ShareholderSell3,000$11.00$33,000.00View SEC Filing  
8/20/2015Jafco Super V3 Investment Limimajor shareholderSell10,683$11.36$121,358.88View SEC Filing  
8/18/2015Jafco Super V3 Investment LimiMajor ShareholderSell11,174$11.71$130,847.54View SEC Filing  
8/13/2015Jafco Super V3 Investment LimiMajor ShareholderSell9,361$11.60$108,587.60View SEC Filing  
2/4/2015M James BarrettMajor ShareholderBuy500,000$10.00$5,000,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Tracon Pharmaceuticals (NASDAQ:TCON)
DateHeadline
investornewswire.com logoTRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Gets 0 Recommendations To Sell - Investor Newswire (NASDAQ:TCON)
www.investornewswire.com - August 26 at 7:21 PM
News IconStock Gapping Up Pre-Bell: TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) - Post News (NASDAQ:TCON)
www.kentuckypostnews.com - August 26 at 10:38 AM
News IconStock Moving Up in Session: TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) - Post News (NASDAQ:TCON)
www.kentuckypostnews.com - August 23 at 12:14 PM
finance.yahoo.com logoTRACON PHARMACEUTICALS, INC. Financials (NASDAQ:TCON)
finance.yahoo.com - August 18 at 7:56 PM
capitalcube.com logoTRACON Pharmaceuticals, Inc. :TCON-US: Earnings Analysis: Q2, 2016 By the Numbers : August 15, 2016 (NASDAQ:TCON)
www.capitalcube.com - August 15 at 8:04 PM
kcregister.com logoTrader's Recap: Ametek Inc. (NYSE:AME), TRACON Pharmaceuticals, Inc. (NASDAQ:TCON), ArcelorMittal SA (ADR ... - KC Register (NASDAQ:TCON)
www.kcregister.com - August 13 at 10:30 AM
finance.yahoo.com logoEdited Transcript of TCON earnings conference call or presentation 10-Aug-16 8:30pm GMT (NASDAQ:TCON)
finance.yahoo.com - August 11 at 8:18 PM
biz.yahoo.com logoTRACON PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report (NASDAQ:TCON)
biz.yahoo.com - August 11 at 11:05 AM
sg.finance.yahoo.com logoTracon reports 2Q loss (NASDAQ:TCON)
sg.finance.yahoo.com - August 10 at 8:17 PM
publicnow.com logoTRACON Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Corporate Update (NASDAQ:TCON)
www.publicnow.com - August 10 at 8:17 PM
biz.yahoo.com logoQ2 2016 TRACON Pharmaceuticals Inc Earnings Release - After Market Close (NASDAQ:TCON)
biz.yahoo.com - August 10 at 10:52 AM
capitalcube.com logoETF’s with exposure to TRACON Pharmaceuticals, Inc. : August 5, 2016 (NASDAQ:TCON)
www.capitalcube.com - August 5 at 7:55 PM
publicnow.com logoTRACON to Report Second Quarter 2016 Company Highlights and Financial Results on August 10, 2016 (NASDAQ:TCON)
www.publicnow.com - August 3 at 8:06 PM
biz.yahoo.com logoTRACON PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:TCON)
biz.yahoo.com - July 29 at 4:03 PM
investornewswire.com logoCan Shares Of TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Hit $14? - Investor Newswire (NASDAQ:TCON)
www.investornewswire.com - July 29 at 10:49 AM
investornewswire.com logoIs $14 Price Target Attainable For TRACON Pharmaceuticals, Inc. (NASDAQ:TCON)? - Investor Newswire (NASDAQ:TCON)
www.investornewswire.com - July 23 at 11:31 AM
News IconStock Up Nicely This Week: TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) - TGP (NASDAQ:TCON)
telanaganapress.com - July 23 at 11:31 AM
News IconEquity Roundup: Stock Performance Focus on TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) - Press Telegraph (NASDAQ:TCON)
presstelegraph.com - July 20 at 8:45 PM
News IconEarnings Focus and Crowd Sourced Sentiment Review for TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) - TGP (NASDAQ:TCON)
telanaganapress.com - July 19 at 8:43 AM
News IconWere Analysts Bearish TRACON Pharmaceuticals Inc (NASDAQ:TCON) This Week? - Consumer Eagle (NASDAQ:TCON)
www.consumereagle.com - July 19 at 8:43 AM
News IconShares Moving Down on the Week: TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) - Engelwood Daily (NASDAQ:TCON)
www.engelwooddaily.com - July 17 at 10:43 AM
fiscalstandard.com logoTRACON Pharmaceuticals, Inc. (TCON) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:TCON)
www.fiscalstandard.com - July 17 at 10:43 AM
News IconShares Experiencing a Downtrend: TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) - TGP (NASDAQ:TCON)
telanaganapress.com - July 16 at 10:54 AM
News IconAnalyst Target and Average Rating Watch: TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) - Press Telegraph (NASDAQ:TCON)
presstelegraph.com - July 14 at 8:01 PM
News IconTRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Earnings Concentration and Analyst Target Watch - Engelwood Daily (NASDAQ:TCON)
www.engelwooddaily.com - July 14 at 8:01 PM
investornewswire.com logoStrong Sell Calls For TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) At 0 - Investor Newswire (NASDAQ:TCON)
www.investornewswire.com - July 14 at 8:01 PM
News IconTRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Wall Street Analyst Recommendation Outlook - Telanagana Press (NASDAQ:TCON)
telanaganapress.com - July 12 at 12:04 PM
News IconSession Volatility Review for: TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) - Engelwood Daily (NASDAQ:TCON)
www.engelwooddaily.com - July 12 at 12:04 PM
News IconHeightened Volatility Check on: TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) - Engelwood Daily (NASDAQ:TCON)
www.engelwooddaily.com - July 8 at 7:42 PM
News IconCompany Stock Focus for TRACON Pharmaceuticals, Inc. (NASDAQ:TCON): Which Way Will Shares Head? - Press Telegraph (NASDAQ:TCON)
presstelegraph.com - July 8 at 7:42 PM
investornewswire.com logoIs $26 Within Reach For TRACON Pharmaceuticals, Inc. (NASDAQ:TCON)? - Investor Newswire (NASDAQ:TCON)
www.investornewswire.com - July 8 at 7:42 PM
fiscalstandard.com logoBroker Outlook For TRACON Pharmaceuticals, Inc. (TCON) - Fiscal Standard (NASDAQ:TCON)
www.fiscalstandard.com - July 8 at 7:42 PM
News IconIncreased Volatility Watch for: TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) - Engelwood Daily (NASDAQ:TCON)
www.engelwooddaily.com - July 6 at 8:10 PM
News IconTRACON Pharmaceuticals Inc (NASDAQ:TCON)'s Company Shares Decreased 43.53% After High Volatility - Engelwood Daily (NASDAQ:TCON)
www.engelwooddaily.com - July 6 at 8:10 PM
fiscalstandard.com logoBroker Outlook For The Week Ahead TRACON Pharmaceuticals, Inc. (TCON) - Fiscal Standard (NASDAQ:TCON)
www.fiscalstandard.com - July 5 at 7:23 PM
News IconShares Touching a Recent Low: TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) - Press Telegraph (NASDAQ:TCON)
presstelegraph.com - July 5 at 7:23 PM
News IconAre Analysts Bullish TRACON Pharmaceuticals Inc (NASDAQ:TCON) After Last Week? - Press Telegraph (NASDAQ:TCON)
presstelegraph.com - July 3 at 10:19 AM
News IconTRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Earnings Glance and Target Price Review - Engelwood Daily (NASDAQ:TCON)
www.engelwooddaily.com - June 30 at 7:54 PM
News IconStock Volatility in Review: TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) - Engelwood Daily (NASDAQ:TCON)
www.engelwooddaily.com - June 29 at 10:29 AM
fiscalstandard.com logoNext Weeks Broker Price Targets For TRACON Pharmaceuticals, Inc. (TCON) - Fiscal Standard (NASDAQ:TCON)
www.fiscalstandard.com - June 27 at 10:20 AM
investornewswire.com logoStrong Sell Calls Recommendations For TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) At 0 - Investor Newswire (NASDAQ:TCON)
www.investornewswire.com - June 23 at 8:28 PM
investornewswire.com logoStrong Buy Calls Count For TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) At 3 - Investor Newswire (NASDAQ:TCON)
www.investornewswire.com - June 17 at 10:24 AM
fiscalstandard.com logoTRACON Pharmaceuticals, Inc. (TCON) Current Analyst Ratings - Fiscal Standard (NASDAQ:TCON)
www.fiscalstandard.com - June 17 at 10:24 AM
kcregister.com logoStock Runners: Asanko Gold Inc. (NYSEMKT:AKG), TRACON Pharmaceuticals, Inc. (NASDAQ:TCON), Navistar ... - KC Register (NASDAQ:TCON)
www.kcregister.com - June 16 at 12:12 PM
biz.yahoo.com logoTRACON PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:TCON)
biz.yahoo.com - June 7 at 7:01 AM
publicnow.com logoTRACON Pharmaceuticals Announces Positive Results from TRC105 and TRC102 Clinical Trials at American Society of Clinical Oncology (ASCO) 2016 Annual Meeting (NASDAQ:TCON)
www.publicnow.com - June 6 at 8:28 AM
finance.yahoo.com logo8:10 am Tracon Pharmaceuticals announces 'Positive' Results from TRC105 and TRC102 Clinical Trials at ASCO; Median PFS greater than 12 months with continued durable complete responses observed in angiosarcoma patients treated with TRC105 an (NASDAQ:TCON)
finance.yahoo.com - June 6 at 8:10 AM
News IconStock Review and Earnings Check on TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) - HNN (NASDAQ:TCON)
hintsnewsnetwork.com - June 3 at 8:25 PM
biz.yahoo.com logoTRACON PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:TCON)
biz.yahoo.com - June 3 at 4:03 PM
News IconTarget Price and Stock Performance Rundown for TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) - HNN (NASDAQ:TCON)
hintsnewsnetwork.com - June 2 at 8:13 PM

Social

Tracon Pharmaceuticals (NASDAQ:TCON) Chart for Monday, August, 29, 2016


Last Updated on 8/29/2016 by MarketBeat.com Staff